Sirius XM shares may quadruple to as much as $8 in the next three years, as the satellite-radio company adds subscribers without many new costs, says Craig Hodges of the Dallas-based Hodges Fund.
As Congress on the verge of voting on a debt deal, the U.S. is "heading toward a prolonged period of austerity" that could affect many sectors, most notably defense and health care, Chuck Gabriel, managing director at Capital Alpha Partners, told CNBC Monday.
The week's top business news and investment advice, including debt bets and commodities plays.
"Depending on our politicians to make business-friendly decisions in a timely manner is certainly not a formula for success," Harry Rady, chief executive of Rady Asset Management, told CNBC Friday.
The only relative safe haven in North American equities in the event of a U.S. default would be Canadian banks, though even they would feel the ripple effects, according to a report from Keefe, Bruyette & Woods.
In the midst of stalled debt talks inching closer to the Aug. 2 deadline when the federal government will run out of money to pay its bills, analysts are split over how the market will react—even if a deal is inked in time.
Americans' craving for coffee is growing and that should mean a boost for Starbucks, UBS senior analyst David Palmer told CNBC Thursday. "One thing about coffee in this country is, behavior is shifting," he said. People are "moving toward the good stuff."
Goldman Sachs raised its 12-month price target on Cisco Systems by 34 percent to $21 Thursday, and upgraded the network company to "buy" from "neutral," based on its expectations of higher earnings in coming quarters.
As the price of crude oil has surged in the last year, several big oil stocks have followed suit. The next quarter will likely deliver good news again for these stocks, said one analyst—but another suggested examining how companies react to oil's rise before investing in them.
Options traders were looking for Staples to ratchet back up after the office-supply retailer fell close to its 52-week lows yesterday.
Discussing the future of the exchange after it abandoned its bid to buy the NYSE, with Robert Greifeld, Nasdaq OMX Group CEO.
In the next 14 months, patents for the top 20 drugs in the U.S. are set to expire. Although makers of such top-selling drugs, such as Lipitor and Plavix, will no longer have a monopoly on these drug formulas, pharmaceutical stocks will be able to weather the loss of these patents, said two health-care analysts.
Hilary Kramer is urging investors to look at these 3 retail stocks even though conventional wisdom is leading investors away from the sector.
McDonald's says it is adding apple slices to every Happy Meal, part of the chain's larger push to paint itself as a healthy place to eat.
Goldman Sachs raised its 2011 through 2013 earnings estimates on Netflix in anticipation of higher prices after the company separates its DVD-by-mail and streaming video plans in September.
As the Aug. 2 deadline to raise the country's $14.3 trillion debt ceiling approaches, investors should expect a downgrade—although it will probably only have a minor impact, said Thomas Lee, JPMorgan's chief U.S. equity strategist.
With the slight dip in the markets attributed to the stalled talks to raise the U.S. debt ceiling and the possibility of a default after the Aug. 2 deadline, analysts were split on whether the U.S. will default and how to play the market if it does, they told CNBC Monday.
Tony Zabiegala doesn't want his clients up at night worrying about market volatility. So to help them sleep well the managing partner at Strategic Wealth Partners told CNBC Monday he advises them to buy defensive, dividend-paying stocks.
With twelve deals on the calendar, the rebound in IPO activity continues and this week is shaping up to be the busiest since November 2007.
Whatever comes out of the debt ceiling talks in Washington, the U.S. is headed toward a period of austerity, BlackRock Chief Equity Analyst Robert Doll told CNBC.